bromodeoxyuridine has been researched along with Bone Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlogie, B; Cottler-Fox, M; Epstein, J; Henderson, A; Wezeman, MJ; Yaccoby, S; Yi, Q | 1 |
| Hattori, T; Inoda, H; Yamamoto, G | 1 |
| D'Angelo, M; Haskins, ME; Schuchman, EH; Simonaro, CM | 1 |
3 other study(ies) available for bromodeoxyuridine and Bone Diseases
| Article | Year |
|---|---|
Cancer and the microenvironment: myeloma-osteoclast interactions as a model.
Topics: Annexin A5; Bone Diseases; Bone Marrow Cells; Bromodeoxyuridine; Carrier Proteins; Cell Differentiation; Cell Division; Cell Movement; Cell Survival; Coculture Techniques; Culture Media, Conditioned; Humans; Interleukin-6; Membrane Glycoproteins; Models, Biological; Multiple Myeloma; NF-kappa B; Osteoclasts; Osteogenesis; Phagocytosis; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B | 2004 |
Histological investigation of osteoinductive properties of rh-BMP2 in a rat calvarial bone defect model.
Topics: Animals; Antimetabolites; Bone Diseases; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bromodeoxyuridine; Cell Proliferation; Collagen; Coloring Agents; Disease Models, Animal; Drug Carriers; Eosine Yellowish-(YS); Fluorescent Dyes; Hematoxylin; Humans; Male; Osteogenesis; Periosteum; Rats; Rats, Wistar; Recombinant Proteins; Skull; Time Factors; Transforming Growth Factor beta | 2004 |
Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models.
Topics: Animals; Antimetabolites; Apoptosis; Biomarkers; Bone Diseases; Bromodeoxyuridine; Cats; Cell Proliferation; Cells, Cultured; Chondrocytes; Cytokines; Disease Models, Animal; Dogs; Immunoassay; Immunohistochemistry; Inflammation; Joint Diseases; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mucopolysaccharidosis VI; Mucopolysaccharidosis VII; Nitric Oxide; Osteonectin; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tibia; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta | 2005 |